FGFR1 rearranged hematological neoplasms - molecularly defined and clinically heterogeneous

被引：7
|
作者：
Patnaik, Mrinal M. [1 ]
Ketterling, Rhett P. [2 ]
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA
来源：
LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 07期
关键词：
LEUKEMIA; FAMILY;
D O I：
10.1080/10428194.2018.1429607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1520 / 1522
页数：3
相关论文
共 50 条
  • [31] Myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement in Vietnam: a case report and literature review
    Chu, Tan-Huy
    Huynh, Thien-Ngon
    Nguyen, Kim-Son
    Phu, Chi-Dung
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 (04) : 498 - 502
  • [32] Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
    Romagnoli, Simone
    Bartalucci, Niccolo
    Gesullo, Francesca
    Balliu, Manjola
    Bonifacio, Stefania
    Fernandez, Anair Graciela Lema
    Mannelli, Francesco
    Bolognini, Davide
    Pelo, Elisabetta
    Mecucci, Cristina
    Guglielmelli, Paola
    Vannucchi, Alessandro Maria
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [33] Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement
    Katagiri, Seiichiro
    Umezu, Tomohiro
    Azuma, Kenko
    Kobayashi, Chiaki
    Akahane, Daigo
    Suguro, Tamiko
    Furuya, Nahoko
    Fujimoto, Hiroaki
    Nakamura, Naoya
    Ohyashiki, Junko H.
    Ohyashiki, Kazuma
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1148 - 1150
  • [34] Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement
    Seiichiro Katagiri
    Tomohiro Umezu
    Kenko Azuma
    Chiaki Kobayashi
    Daigo Akahane
    Tamiko Suguro
    Nahoko Furuya
    Hiroaki Fujimoto
    Naoya Nakamura
    Junko H. Ohyashiki
    Kazuma Ohyashiki
    Bone Marrow Transplantation, 2019, 54 : 1148 - 1150
  • [35] Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
    Tefferi, Ayalew
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (02) : 215 - 237
  • [36] Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2
    Baer, Constance
    Muehlbacher, Verena
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    HAEMATOLOGICA, 2018, 103 (08) : E348 - E350
  • [37] Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis
    Liu, Yajuan J.
    Wang, Wenjing
    Yeh, Jeffrey
    Wu, Yu
    Mantilla, Jose G.
    Fletcher, Christopher D. M.
    Ricciotti, Robert W.
    Chen, Eleanor Y.
    MODERN PATHOLOGY, 2021, 34 (07) : 1373 - 1383
  • [38] FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features
    Baldazzi, Carmen
    Luatti, Simona
    Paolini, Stefania
    Papayannidis, Cristina
    Marzocchi, Giulia
    Ameli, Gaia
    Martinelli, Giovanni
    Cavo, Michele
    Testoni, Nicoletta
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (03) : E14 - E16
  • [39] FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract
    Chu, Ying-Hsia
    Mullaney, Kerry
    Dinapoli, Sara E.
    Cohen, Marc A.
    Xu, Bin
    Ghossein, Ronald
    Katabi, Nora
    Dogan, Snjezana
    HISTOPATHOLOGY, 2024, 84 (04) : 589 - 600
  • [40] Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
    Verena Patterer
    Susanne Schnittger
    Wolfgang Kern
    Torsten Haferlach
    Claudia Haferlach
    Annals of Hematology, 2013, 92 : 759 - 769
12345